DOCS Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
156.6M
+7.7%
145.4M
-21.4%
185.1M
+9.8%
168.5M
+15.5%
145.9M
Cost of Revenue
23.7M
+22.1%
19.4M
+3.8%
18.7M
+13.9%
16.4M
+4.0%
15.8M
Gross Profit
132.9M
+5.5%
126.0M
-24.3%
166.4M
+9.4%
152.1M
+16.9%
130.1M
Operating Expenses
99.3M
-1.8%
101.1M
+7.1%
94.5M
+6.8%
88.4M
+17.0%
75.6M
R&D
38.5M
-1.6%
39.1M
+13.0%
34.6M
+14.5%
30.2M
+12.7%
26.8M
SG&A
60.8M
-2.0%
62.0M
+3.6%
59.9M
+2.8%
58.2M
+19.3%
48.8M
Operating Income
33.6M
+35.5%
24.8M
-65.5%
71.9M
+12.9%
63.7M
+16.8%
54.5M
EBITDA
37.9M
+14.4%
33.2M
-57.7%
78.4M
+11.9%
70.0M
+22.2%
57.3M
Net Income
24.3M
+27.2%
19.1M
-68.9%
61.6M
-0.8%
62.1M
+16.4%
53.3M
EPS (Basic)
$0.13
+30.0%
$0.10
-69.7%
$0.33
+0.0%
$0.33
+17.9%
$0.28
EPS (Diluted)
$0.13
+30.0%
$0.10
-67.7%
$0.31
+0.0%
$0.31
+14.8%
$0.27
Shares (Diluted)
191.2M
-2.0%
195.1M
-2.1%
199.2M
-0.8%
200.7M
-0.2%
201.2M